The ins and outs of transcriptional control: Nucleocytoplasmic shuttling in development and disease

Trends in Genetics

Volumn 20, Issue 1, 2004, Pages 4-8

  Smith, James M ^a   Koopman, Peter A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR;

CELL NUCLEUS; CYTOPLASM; DEVELOPMENT; DEVELOPMENTAL DISORDER; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; NUCLEAR IMPORT; NUCLEOCYTOPLASMIC TRANSPORT; ORGANOGENESIS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION;

EID: 0346157329     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2003.11.007     Document Type: Short Survey

References (40)

1. Fischer U., et al. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell. 82:1995;475-483.
2. Mowen K., David M. Regulation of STAT1 nuclear export by Jak1. Mol. Cell. Biol. 20:2000;7273-7281.
3. Neufeld K.L., et al. Ademotatous polyposis coli protein contains two nuclear export signals and shuttles between the nucleus and cytoplasm. Proc. Natl. Acad. Sci. U. S. A. 97:2000;12085-12090.
4. Stommel J.M., et al. A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking. EMBO J. 18:1999;1660-1672.
5. Rodriguez J.A., Henderson B.R. Identification of a functional nuclear export signal in BRCA1. J. Biol. Chem. 275:2000;38589-38596.
6. Watanabe M., et al. Regulation of intracellular dynamics of Smad4 by its leucine-rich nuclear export signal. EMBO Rep. 1:2000;176-182.
7. Fabbro M., Henderson B.R. Regulation of tumour suppressors by nuclear-cytoplasmic shuttling. Exp. Cell Res. 282:2003;59-69.
8. Li B., et al. Human sex reversal due to impaired nuclear localization of SRY - a clinical correlation. J. Biol. Chem. 276:2001;46480-46484.
9. Preiss S., et al. Compound effects of point mutations causing campomelic dysplasia/autosomal sex reversal upon SOX9 structure, nuclear transport, DNA binding, and transcriptional activation. J. Biol. Chem. 276:2001;27864-27872.
10. Gasca S., et al. A nuclear export signal within the high mobility group domain regulates the nucleocytoplasmic translocation of SOX9 during sexual determination. Proc. Natl. Acad. Sci. U. S. A. 99:2002;11199-11204.
11. Rehberg S., et al. Sox10 is an active nucleocytoplasmic shuttle protein, and shuttling is crucial for Sox10-mediated transactivation. Mol. Cell. Biol. 22:2002;5826-5834.
12. Numabe H., et al. DNA analyses of XX and XX-hypospadiac males. Hum. Genet. 90:1992;211-214.
13. Fechner P.Y., et al. The role of the sex determining region Y gene in the etiology of 46,XX maleness. J. Clin. Endocrinol. Metab. 76:1993;690-695.
14. Giese K., et al. Distinct DNA-binding properties of the high mobility group domain of murine and human SRY sex-determining factors. Proc. Natl. Acad. Sci. U. S. A. 91:1994;3368-3374.
15. Pontiggia A., et al. Sex-reversing mutations affect the architecture of SRY-DNA complexes. EMBO J. 13:1994;6115-6124.
16. Koopman P.A. Sry, Sox9 and mammalian sex determination. Scherer G., Schmid M. Genes and Mechanisms in Vertebrate Sex Determination. 2001;25-56 Birkhauser-Verlag.
17. Südbeck P., Scherer G. Two independent nuclear localization signals are present in the DNA-binding high mobility group domains of SRY and SOX9. J. Biol. Chem. 272:1997;27848-27852.
18. Forwood J., et al. The C-terminal nuclear localization signal of the sex determining region Y (SRY) high mobility group domain mediates nuclear import through importin beta 1. J. Biol. Chem. 276:2001;46575-46582.
19. Kohler M., et al. Nuclear protein transport pathways. Exp. Nephrol. 7:1999;290-294.
20. Harley V.R., et al. The HMG box of SRY is a calmodulin binding domain. FEBS Lett. 391:1996;24-28.
21. Harley V.R., et al. Defective importin β recognition and nuclear import of the sex-determining factor SRY are associated with XY sex-reversing mutations. Proc. Natl. Acad. Sci. U. S. A. 100:2003;7045-7050.
22. Bowles J., et al. Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Developmental Biology. 227:2000;239-255.
23. Wilson M., Koopman P. Matching SOX: partner proteins and co-factors of the SOX family of transcriptional regulators. Curr. Opin. Genet. Dev. 12:2002;441-446.
24. Wright E., et al. The Sry-related gene Sox-9 is expressed during chondrogenesis in mouse embryos. Nat. Genet. 9:1995;15-20.
25. Bi W., et al. Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc. Natl. Acad. Sci. U. S. A. 98:2001;6698-6703.
26. Houston C.S., et al. The campomelic syndrome: review, report of 17 cases, and follow-up on the currently 17- year old boy first reported by Maroteaux et al. in 1971. Am. J. Med. Genet. 15:1983;3-28.
27. Kent J., et al. A male-specific role for SOX9 in vertebrate sex determination. Development. 122:1996;2813-2822.
28. Morais da Silva S., et al. Sox9 expression during gonadal development implies a conserved role for the gene in testis differentiation in mammals and birds. Nat. Genet. 14:1996;62-68.
29. Vidal V., et al. Sox9 induces testis development in XX transgenic mice. Nat. Genet. 28:2001;216-217.
30. Koopman P., et al. Male development of chromosomally female mice transgenic for Sry. Nature. 351:1991;117-121.
31. Clarkson M.J., Harley V.R. Sex with two SOX on: SRY and SOX9 in testis development. Trends Endocrinol. Metab. 13:2002;106-111.
32. Bernard P., et al. Dimerization of SOX9 is required for chondrogenesis, but not for sex determination. Hum. Mol. Genet. 12:2003;1755-1765.
33. Sock E., et al. Loss of DNA-dependent dimerization of the transcription factor SOX9 as a cause for campomelic dysplasia. Hum. Mol. Genet. 12:2003;1439-1447.
34. Südbeck P., et al. Sex reversal by loss of the C-terminal transactivation domain of human SOX9. Nat. Genet. 13:1996;230-232.
35. Argentaro A., et al. A SOX9 defect of calmodulin-dependent nuclear import in campomelic dysplasia/autosomal sex reversal. J. Biol. Chem. 278:2003;33839-33847.
36. de Santa Barbara P., et al. Expression and subcellular localization of SF-1, SOX9, WT1, and AMH proteins during early human testicular development. Dev. Dyn. 217:2000;293-298.
37. Pingault V., et al. SOX10 mutations in patients with Waardenburg- Hirschsprung disease. Nat. Genet. 18:1998;171-173.
38. Bowles J., et al. Phylogeny of the SOX family of developmental transcription factors based on sequence and structural indicators. Dev. Biol. 227:2000;239-255.
39. Gasiorowski J.Z., Dean D.A. Mechanisms of nuclear transport and interventions. Adv. Drug Deliv. Rev. 55:2003;703-716.
40. Harley V.R., et al. The molecular action and regulation of the testis-determining factors, SRY (Sex-determining Region on the Y chromosome) and SOX9 (SRY-related high-mobility group (HMG) Box 9). Endocr. Rev. 24:2003;466-487.